Table I. Primer sequences used in the study.

ALCAM: Activated leukocyte cell adhesion molecule; ALDHA2: aldehyde dehydrogenase 2 family member; B4GALNT1: beta-1,4-n-acetyl-galactosaminyltransferase 1; B4GALT4: beta-1,4-galactosyltransferase 4; BMI1: BMI1 polycomb ring finger proto-oncogene; CD: cluster of differentiation; CK19: cytokeratin-19; cMYC: Myc proto-oncogene protein; CtBP: C-terminal binding protein 1; CX43: connexin 43; hTERT2: human telomerase reverse transcriptase 2; IL: interleukin; L1CAM: L1 cell adhesion molecule; LGR5: leucine rich repeat containing G protein-coupled receptor 5; MET: MET proto-oncogene; NGFR: nerve growth factor receptor; NGF: nerve growth factor; Notch1: Notch receptor 1; Notch2: Notch receptor 2; OCT4: octamer-binding protein 4; PSCA: prostate stem cell antigen; SLUG: Slug homolog, zinc finger protein; SNAIL: Snail family transcriptional repressor 1; ST8Sia1: ST8 alpha-n-acetyl-neuraminide alpha-2,8-sialyltransferase 1; STAT5: signal transducer and activator of transcription 5A; TSA: thymic shared antigen-1; TWIST: twist basic helix-loop-helix transcription factor.